Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NCT04910269 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

820

Enrollment

OTHER

Sponsor class

Conditions

COVID
SARS-CoV2 Infection
Covid19

Interventions

BIOLOGICAL: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
OTHER: Placebo

Sponsor

University of Minnesota

Collaborators

[object Object]
[object Object]
[object Object]